# Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/baricitinib-versus-placebo-or-adalimumab-in-rheumatoid-arthritis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter C. Taylor,Edward Keystone,Désirée van der Heijde,Michael E. Weinblatt,Liliana Morales,Jaime Reyes Gonzaga,S. S. Yаkushin,Taeko Ishii,Kahaku Emoto,Scott D. Beattie,Vipin Arora,C. Gaich,Terence Rooney,Douglas Schlichting,William L. Macias,Stephanie de Bono,Yoshiya Tanaka |
| Citations | 961 |
| DOI | 10.1056/nejmoa1608345 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1608345?articleTools=true |
| OpenAlex ID | https://openalex.org/W2588044396 |
| PMID | 28199814 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Yoshiya Tanaka](https://scholariq.org/researchers/yoshiya-tanaka/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.